We are live on ! Find out more
PVCT

PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT

Delisted

PVCT was delisted on the 13th of October, 2016.

7 hedge funds and large institutions have $22.9K invested in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more funds holding

Funds holding: 67 (+1)

8% more capital invested

Capital invested by funds: $21.2K → $22.9K (+$1.66K)

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

PVCT Hedge Fund Activity: Q1 2025 in Review

7 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) for Q1 2025, worth a combined $22.9K — up 7.8% from $21.2K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new PVCT positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

  • 7 institutional investors held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) as of Q1 2025, up from 6 in Q4 2024.
  • Funds reported $22.9K of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) stock for Q1 2025, up 7.8% quarter-over-quarter.
  • 1 fund opened new PROVECTUS BIOPHARMACEUTICALS, INC. (DE) positions in Q1 2025 and 0 closed out, a net change of +1 holder.

Based on aggregated 13F filings for Q1 2025.